RT @salinejapan: ...Duloxetine is the only agent that has appropriate evidence to support its use for patients with established painful CIP…
RT @salinejapan: ...Duloxetine is the only agent that has appropriate evidence to support its use for patients with established painful CIP…
...Duloxetine is the only agent that has appropriate evidence to support its use for patients with established painful CIPN. https://t.co/xtxlpsLhS8
少し古いですがASCOガイドラインでは、CIPNが深刻化する場合にはChemotherapyの延期、用量の減量、または中止を検討することが推奨されています(moderate)。 CIPNを把握し、適切に対峙することが重要です。 https://t.co/a3qeuzUh2P
@shewolf1877 I'm doing well on gabapentin but "Duloxetine is the only agent that has appropriate evidence to support its use for patients with established painful CIPN" https://t.co/ZVoMsQccLh
Prior cumulative exposure to oxaliplatin would come into play. Too often overused. 6 months of chemo doesn’t mean 6 months of oxaliplatin. #TargetedChat #CRCSM #ColorectalCancer #ColorectalCancerAwarenessMonth
RT @pashtoonkasi: @TargetedOnc @ALLIANCE_org 3/ Prior cumulative neuropathy on oxaliplatin affects choice. More difficult if they already h…
RT @pashtoonkasi: @TargetedOnc @ALLIANCE_org 3/ Prior cumulative neuropathy on oxaliplatin affects choice. More difficult if they already h…
@TargetedOnc @ALLIANCE_org 3/ Prior cumulative neuropathy on oxaliplatin affects choice. More difficult if they already have residual neuropathy; esp. if they got 6 months of chemotherapy. Important to be able to quantify cumulative exposure/residual side
Chemotherapy Induced Peripheral Neuropathy management, Duloxetine is the only agent that has appropriate evidence to support its use for patients with established painful CIPN. Nonetheless, the amount of benefit from duloxetine is limited. https://t.co/3T
RT @Pharma_nishi: ※補足です 「休薬・減量が最も期待できる」というのは「末梢神経障害を起こす抗がん剤の休薬・減量」です🙏🏻 また痺れて「痛い」という症状には、効果が期待できることが多いように思います (参考文献) https://t.co/pkm6ax2…
RT @Pharma_nishi: ※補足です 「休薬・減量が最も期待できる」というのは「末梢神経障害を起こす抗がん剤の休薬・減量」です🙏🏻 また痺れて「痛い」という症状には、効果が期待できることが多いように思います (参考文献) https://t.co/pkm6ax2…
※補足です 「休薬・減量が最も期待できる」というのは「末梢神経障害を起こす抗がん剤の休薬・減量」です🙏🏻 また痺れて「痛い」という症状には、効果が期待できることが多いように思います (参考文献) https://t.co/pkm6ax2nc8
RT @drcbsteer: @CANsurvive @OncoAlert @CancerCareMASCC @maryam_lustberg @JAMA_current @JAMANetwork Given this is just a 2 page summary of t…
RT @drcbsteer: @CANsurvive @OncoAlert @CancerCareMASCC @maryam_lustberg @JAMA_current @JAMANetwork Given this is just a 2 page summary of t…
RT @drcbsteer: @CANsurvive @OncoAlert @CancerCareMASCC @maryam_lustberg @JAMA_current @JAMANetwork Given this is just a 2 page summary of t…
@CANsurvive @OncoAlert @CancerCareMASCC @maryam_lustberg @JAMA_current @JAMANetwork Given this is just a 2 page summary of the 2020 @ASCO #supportivecare guidelines and is published as a “JAMA Clinical Guidelines Synopsis” I think it’s best continuing to u
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update @ALLIANCE_org https://t.co/PJBGop5BCa
RT @COSA_Surviv: Chemotherapy-Induced Peripheral Neuropathy is an important issue for so many #cancersurvivors Did you know the @ASCO_pubs…
RT @COSA_Surviv: Chemotherapy-Induced Peripheral Neuropathy is an important issue for so many #cancersurvivors Did you know the @ASCO_pubs…
RT @COSA_Surviv: Chemotherapy-Induced Peripheral Neuropathy is an important issue for so many #cancersurvivors Did you know the @ASCO_pubs…
RT @COSA_Surviv: Chemotherapy-Induced Peripheral Neuropathy is an important issue for so many #cancersurvivors Did you know the @ASCO_pubs…
RT @COSA_Surviv: Chemotherapy-Induced Peripheral Neuropathy is an important issue for so many #cancersurvivors Did you know the @ASCO_pubs…
RT @COSA_Surviv: Chemotherapy-Induced Peripheral Neuropathy is an important issue for so many #cancersurvivors Did you know the @ASCO_pubs…
RT @COSA_Surviv: Chemotherapy-Induced Peripheral Neuropathy is an important issue for so many #cancersurvivors Did you know the @ASCO_pubs…
RT @COSA_Surviv: Chemotherapy-Induced Peripheral Neuropathy is an important issue for so many #cancersurvivors Did you know the @ASCO_pubs…
RT @COSA_Surviv: Chemotherapy-Induced Peripheral Neuropathy is an important issue for so many #cancersurvivors Did you know the @ASCO_pubs…
RT @COSA_Surviv: Chemotherapy-Induced Peripheral Neuropathy is an important issue for so many #cancersurvivors Did you know the @ASCO_pubs…
Chemotherapy-Induced Peripheral Neuropathy is an important issue for so many #cancersurvivors Did you know the @ASCO_pubs guidelines for prevention and management of #CIPN were updated last year? 👀 https://t.co/GNoqMrquTn #cancersurvivorship #survonc #
RT @VanitaNoronha: No agent is approved for the prevention of chemo-induced peripheral neuropathy. Duloxetine is the only drug with good ev…
RT @M_Jefford: Take homes from @tsmit136 on neuropathy #surv21 #survonc #CIPN @ASCO guidance on CIPN at https://t.co/r5ZqVL1JoH https://t.c…
Take homes from @tsmit136 on neuropathy #surv21 #survonc #CIPN @ASCO guidance on CIPN at https://t.co/r5ZqVL1JoH https://t.co/q5bjDaqnLP
RT @BZavaletaMD: The most recent review article from @ASCO_pubs on chemo-induced #neuropathy: 1. Duloxetine works for pain 2. Nothing work…
In @colontown, we recommend #icingduringoxaliplatin to all patients on oxaliplatin containing chemo. It seems pretty effective in preventing/reducing acute cold sensitivity. We are still waiting to see if there is any effect on peripheral neuropathy
@DrAttai Honestly nothing yet has been proven with high quality evidence to prevent. But I do recommend icing because it can’t hurt and there is randomized data. Here is ASCO’s summary. https://t.co/wHUaDAFffn
RT @Farm_Torrecard: #Guía #ASCO de #prevención y #tratamiento de la #neuropatíaperiférica asociada al tratamiento #antineoplásico https://…
RT @farma_gregorio: Guía ASCO sobre la prevención y tratamiento de la neuropatía periférica asociada al tratamiento antineoplásico https:/…
RT @farma_gregorio: Guía ASCO sobre la prevención y tratamiento de la neuropatía periférica asociada al tratamiento antineoplásico https:/…
RT @Farm_Torrecard: #Guía #ASCO de #prevención y #tratamiento de la #neuropatíaperiférica asociada al tratamiento #antineoplásico https://…
RT @Farm_Torrecard: #Guía #ASCO de #prevención y #tratamiento de la #neuropatíaperiférica asociada al tratamiento #antineoplásico https://…
RT @Farm_Torrecard: #Guía #ASCO de #prevención y #tratamiento de la #neuropatíaperiférica asociada al tratamiento #antineoplásico https://…
#Guía #ASCO de #prevención y #tratamiento de la #neuropatíaperiférica asociada al tratamiento #antineoplásico https://t.co/LROYYzTe7O https://t.co/MmwZpCTa14
RT @farma_gregorio: Guía ASCO sobre la prevención y tratamiento de la neuropatía periférica asociada al tratamiento antineoplásico https:/…
RT @farma_gregorio: Guía ASCO sobre la prevención y tratamiento de la neuropatía periférica asociada al tratamiento antineoplásico https:/…
RT @farma_gregorio: Guía ASCO sobre la prevención y tratamiento de la neuropatía periférica asociada al tratamiento antineoplásico https:/…
RT @farma_gregorio: Guía ASCO sobre la prevención y tratamiento de la neuropatía periférica asociada al tratamiento antineoplásico https:/…
RT @farma_gregorio: Guía ASCO sobre la prevención y tratamiento de la neuropatía periférica asociada al tratamiento antineoplásico https:/…
Guía ASCO sobre la prevención y tratamiento de la neuropatía periférica asociada al tratamiento antineoplásico https://t.co/1IvWUdCuEy https://t.co/5XbI724Fuq
RT @BelletMeritxell: Awesome review in J Clin Oncol! An important issue for many cancer patients.https://t.co/jzPsLah6us @OncoAlert https:/…
RT @BelletMeritxell: Awesome review in J Clin Oncol! An important issue for many cancer patients.https://t.co/jzPsLah6us @OncoAlert https:/…
RT @BelletMeritxell: Awesome review in J Clin Oncol! An important issue for many cancer patients.https://t.co/jzPsLah6us @OncoAlert https:/…
RT @BelletMeritxell: Awesome review in J Clin Oncol! An important issue for many cancer patients.https://t.co/jzPsLah6us @OncoAlert https:/…
RT @BelletMeritxell: Awesome review in J Clin Oncol! An important issue for many cancer patients.https://t.co/jzPsLah6us @OncoAlert https:/…
RT @BelletMeritxell: Awesome review in J Clin Oncol! An important issue for many cancer patients.https://t.co/jzPsLah6us @OncoAlert https:/…
RT @BelletMeritxell: Awesome review in J Clin Oncol! An important issue for many cancer patients.https://t.co/jzPsLah6us @OncoAlert https:/…
Awesome review in J Clin Oncol! An important issue for many cancer patients.https://t.co/jzPsLah6us @OncoAlert https://t.co/Sgsix5RN0f
RT @BZavaletaMD: The most recent review article from @ASCO_pubs on chemo-induced #neuropathy: 1. Duloxetine works for pain 2. Nothing work…
RT @BZavaletaMD: The most recent review article from @ASCO_pubs on chemo-induced #neuropathy: 1. Duloxetine works for pain 2. Nothing work…
@LillyPad
@DisarmTx
RT @BZavaletaMD: The most recent review article from @ASCO_pubs on chemo-induced #neuropathy: 1. Duloxetine works for pain 2. Nothing work…
RT @BZavaletaMD: The most recent review article from @ASCO_pubs on chemo-induced #neuropathy: 1. Duloxetine works for pain 2. Nothing work…
RT @BZavaletaMD: The most recent review article from @ASCO_pubs on chemo-induced #neuropathy: 1. Duloxetine works for pain 2. Nothing work…
@Sapere_vivere This is a pretty comprehensive review by @ASCO https://t.co/B5XCSEmJpm that has some suggestions
The most recent review article from @ASCO_pubs on chemo-induced #neuropathy: 1. Duloxetine works for pain 2. Nothing works to prevent 3. No rec’s yet on acupuncture, exercise, cryotherapy, compression - but prelim evidence shows promise #cancer #survonc
Prevention and management of chemotherapy induced peripheral neuropathy and survivors of adult cancers ASCO guideline update: Conclusion is nothing prevents PN chemotherapy induced, but Duloxetine has evidence to treat symptoms in pts with painful PN http
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update https://t.co/Fyxo72u8Th
New2Trip: Prevention & Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers https://t.co/7MUwgIYrYK
RT @VanitaNoronha: No agent is approved for the prevention of chemo-induced peripheral neuropathy. Duloxetine is the only drug with good ev…
RT @VanitaNoronha: No agent is approved for the prevention of chemo-induced peripheral neuropathy. Duloxetine is the only drug with good ev…
RT @VanitaNoronha: No agent is approved for the prevention of chemo-induced peripheral neuropathy. Duloxetine is the only drug with good ev…
RT @VanitaNoronha: No agent is approved for the prevention of chemo-induced peripheral neuropathy. Duloxetine is the only drug with good ev…
RT @VanitaNoronha: No agent is approved for the prevention of chemo-induced peripheral neuropathy. Duloxetine is the only drug with good ev…
"Duloxetine is the only agent that has appropriate evidence to support its use for patients with established painful CIPN."https://t.co/Xir832eLpg
RT @VanitaNoronha: No agent is approved for the prevention of chemo-induced peripheral neuropathy. Duloxetine is the only drug with good ev…
RT @VanitaNoronha: No agent is approved for the prevention of chemo-induced peripheral neuropathy. Duloxetine is the only drug with good ev…
RT @VanitaNoronha: No agent is approved for the prevention of chemo-induced peripheral neuropathy. Duloxetine is the only drug with good ev…
RT @VanitaNoronha: No agent is approved for the prevention of chemo-induced peripheral neuropathy. Duloxetine is the only drug with good ev…
No agent is approved for the prevention of chemo-induced peripheral neuropathy. Duloxetine is the only drug with good evidence for therapy of established painful chemo-induced peripheral neuropathy. #oncoalert https://t.co/nustqRHPQK
RT @tripdatabase: New2Trip: Prevention & Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers https://t.c…
New2Trip: Prevention & Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers https://t.co/wrXJMsWv7V
New2Trip: Prevention & Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers https://t.co/7MUwgIYrYK
New2Trip: Prevention & Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers https://t.co/7MUwgIYrYK
New2Trip: Prevention & Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers https://t.co/7MUwgIYrYK
RT @MOCBrasil: Atualização das Diretrizes da ASCO 2020 sobre Prevenção e Manejo de Neuropatia Periférica induzida por quimioterapia em paci…
New2Trip: Prevention & Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers https://t.co/7MUwgIYrYK
RT @MOCBrasil: Atualização das Diretrizes da ASCO 2020 sobre Prevenção e Manejo de Neuropatia Periférica induzida por quimioterapia em paci…
RT @MOCBrasil: Atualização das Diretrizes da ASCO 2020 sobre Prevenção e Manejo de Neuropatia Periférica induzida por quimioterapia em paci…
New2Trip: Prevention & Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers https://t.co/7MUwgIYrYK
RT @MOCBrasil: Atualização das Diretrizes da ASCO 2020 sobre Prevenção e Manejo de Neuropatia Periférica induzida por quimioterapia em paci…
RT @MOCBrasil: Atualização das Diretrizes da ASCO 2020 sobre Prevenção e Manejo de Neuropatia Periférica induzida por quimioterapia em paci…
RT @MOCBrasil: Atualização das Diretrizes da ASCO 2020 sobre Prevenção e Manejo de Neuropatia Periférica induzida por quimioterapia em paci…
RT @MOCBrasil: Atualização das Diretrizes da ASCO 2020 sobre Prevenção e Manejo de Neuropatia Periférica induzida por quimioterapia em paci…
Atualização das Diretrizes da ASCO 2020 sobre Prevenção e Manejo de Neuropatia Periférica induzida por quimioterapia em pacientes oncológicos sobreviventes https://t.co/kQTHJS1Vmb #neuropathy @ASCO_pubs @rcarvalhoonco @DGagliato @camillayamada @FabioSchut
New2Trip: Prevention & Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers https://t.co/7MUwgIYrYK
RT @ASCO_pubs: .@ASCO guideline update: Prevention & management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers…
RT @ASCO_pubs: .@ASCO guideline update: Prevention & management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers…